Skip to main content
SpringerLink
Log in

Baricitinib/dexamethasone/remdesivir

Worsening of aspiration pneumonia following off-label use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nagasawa R, et al. Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Internal Medicine 62: 3125-3130, No. 21, Nov 2023. Available from: URL: https://dx.doi.org/10.2169/internalmedicine.0761-22

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baricitinib/dexamethasone/remdesivir. Reactions Weekly 1990, 32 (2024). https://doi.org/10.1007/s40278-024-52389-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52389-6

Search

Navigation